Shruti H. Mehta, PhD
- Division: Infectious Disease Epidemiology
Center & Institute Affiliations
615 N. Wolfe Street
Baltimore, Maryland 21205
PhD, Johns Hopkins Bloomberg School of Public Health, 2002
MPH, Johns Hopkins Bloomberg School of Public Health, 1998
Primary research interests include working with hard-to reach populations to understand the epidemiology, natural and treated history of HIV, hepatitis C virus (HCV) and HIV/HCV co-infection; Populations of interest include injection drug users and men who have sex with men as well as their sexual partners in both Baltimore and international settings, particularly India; Special interest in identifying and overcoming barriers to care and treatment of HIV and hepatitis C virus among such populations.
- HIV, Hepatitis C, injection drug users, HIV/HCV co-infection
Mehta SH, Kirk GD, Astemborski J, Galai N, Celentano DD. Temporal trends in HAART initiation among injection drug users in Baltimore, MD, 1996-2008. Clin Infect Dis (In Press).
Nandi A, Glass TA, Cole SR, Chu H, Galea S, Celentano DD, Kirk GD, Vlahov D, Lattimer WW, Mehta SH. Neighborhood poverty and injection cessation in a sample of injection drug users 2010;171:391-8.
Solomon SS, Celentano DD, Srikrishnan AK, Vasudevan CK, Anand S, Kumar MS, Solomon S, Lucas GM, Mehta SH. Mortality among injection drug users in Chennai, India (2005-2008). AIDS 2009;23:997-1004.
Kavasery R, Galai N, Astemborski J, Lucas GM, Celentano DD, Kirk GD, Mehta SH. Non-structured treatment interruptions (NTIs) among injection drug users in Baltimore, MD. J Acquire Immune Defic Syndr 2009;50:360-6.
- ALIVE - AIDS Linked to the IntraVenous Experience
- Hepatitis C
- MIDACS- Madras Injection Drug User and AIDS Cohort Study
- SHIELD - The Study of HIV Infection in the Etiology of Lung Disease